A Bona Fide Physician-Patient Relationship is a legally defined clinical connection established through a complete medical evaluation, review of patient history, and ongoing care responsibility that most states require a physician to have with a patient before issuing a medical marijuana certification.
How the Bona Fide Standard Differs from a Standard Consultation
The term “bona fide” Latin for “in good faith” carries specific legal weight in the context of medical marijuana certification. It distinguishes a genuine, ongoing clinical relationship from a transactional encounter designed solely to produce a recommendation document.
A standard medical consultation may be a one-time interaction for a narrow clinical purpose, a walk-in visit for an acute complaint, a second opinion, or a specialist referral review. A bona fide relationship, by contrast, implies a broader and more durable clinical connection. The physician must have sufficient knowledge of the patient’s medical history, current health status, and treatment trajectory to make a responsible, individualized recommendation not a generalized one based on a brief intake form.
In practical terms, this means the certifying physician cannot simply review a patient’s self-reported symptoms and issue a cannabis certification without conducting a substantive clinical evaluation. The relationship must reflect genuine medical judgment, grounded in the patient’s documented history and the physician’s direct assessment.
What States Require to Establish a Bona Fide Relationship
States that use the bona fide standard in their Medical Marijuana Program legislation typically codify several specific elements that must be present before a physician can legally certify a patient. While exact language varies by jurisdiction, the core requirements consistently include:
Complete Medical History Review: The physician must review the patient’s full medical history not just the condition for which cannabis is being sought. This includes prior diagnoses, current and past medications, treatment outcomes, relevant specialist notes, and any conditions that could affect how the patient responds to cannabis or that might contraindicate its use.
In-Person or Synchronous Telemedicine Evaluation: The physician must conduct a direct evaluation either face-to-face or via live video that allows them to assess the patient’s current condition firsthand. Asynchronous communications such as email reviews, pre-recorded video submissions, or questionnaire-only assessments do not satisfy the bona fide standard in any state that applies it.
Diagnosis of a Qualifying Condition: The evaluation must result in the physician’s independent confirmation that the patient has a state-recognized qualifying medical condition, not simply the patient’s self-report of a diagnosis. The physician must be able to document the clinical basis for that confirmation.
Ongoing Care Responsibility: Most states specify that the bona fide relationship includes a commitment to ongoing follow-up. The physician should be available to monitor the patient’s response to cannabis treatment, adjust the recommendation if the clinical picture changes, and provide continuity of care through the annual renewal cycle.
Why the Bona Fide Standard Exists in State Law
The bona fide requirement was introduced into state medical marijuana statutes in direct response to early program abuses. In the first wave of state-level cannabis legalization, a small number of physicians operated high-volume certification practices with minimal clinical rigor issuing recommendations in bulk after brief encounters that bore little resemblance to genuine medical care. These practices attracted regulatory scrutiny and threatened the legitimacy of emerging medical cannabis programs.
By codifying the bona fide standard, states ensured that the physician’s role in the cannabis certification process would reflect the same standards of care expected in any other area of medicine. The requirement protects patients by ensuring that the physician issuing a certification actually knows enough about them to do so responsibly. It protects physicians by giving them a clear legal standard to meet and document. And it protects the Medical Marijuana Program as an institution by maintaining the credibility of the medical gatekeeping function that justifies the program’s existence under state law.
States without explicit bona fide language in their cannabis statutes typically achieve the same outcome through general medical practice standards; a physician who certifies a patient without conducting a proper evaluation remains subject to medical board discipline regardless of whether the word “bona fide” appears in the relevant statute.
How Patients Can Ensure the Standard Is Met
For patients, the bona fide requirement is not a burden, it is a protection. It guarantees that the physician issuing their certification has actually evaluated their condition and is making a recommendation that reflects genuine clinical judgment. A certification produced through a process that does not meet this standard is legally vulnerable and may be rejected by the state registry during the application process.
To ensure the standard is met, patients should select a cannabis-certifying physician who conducts a thorough intake process, one that requests prior medical records, asks substantive questions about symptom history and prior treatments, and conducts a live evaluation rather than relying solely on self-reported data. Patients should be prepared to share documentation of their qualifying diagnosis, including specialist letters or diagnostic records, to support the physician’s independent assessment.
The evaluation itself should feel like a genuine medical appointment. If a certification process feels cursory, no review of records, no direct clinical questions, no discussion of cannabis as a treatment, patients should treat that as a signal that the bona fide standard may not be met. A Medical Marijuana Card issued through a properly conducted bona fide evaluation is not only legally valid, it is the foundation of a supervised treatment relationship that serves the patient’s long-term clinical interests.
